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Constitutive expression of the type I interferon-inducible human cytoplasmic MxA protein has been shown to interfere
with primary transcription of vesicular stomatitis virus (VSV) in tissue culture cells. As phosphorylation of the VSV P protein
has been linked to its ability to stimulate viral transcription, we analyzed the phosphorylation status of this protein in human
brain cells (U-87) stably transfected with MxA. We observed a general increase in cellular kinase activity in the presence
of MxA, affecting both cellular proteins and VSV P protein. Phosphorylation of the latter was up to threefold higher both in
vivo and in vitro. In vitro phosphorylation of recombinant VSV P protein could be enhanced in MxA-negative cell extracts
after exogenous addition of recombinant His-MxA. Biochemical evidence and phosphorylation of a mutant P protein lacking
the recognized casein kinase II (CKII) sites suggested that hyperphosphorylation of VSV P protein was not due to a stimulation
of CKII. We thus propose that expression of MxA in human brain cells is associated with the stimulation of a cellular kinase
that is active in phosphorylating both cellular target proteins and VSV P protein. q 1996 Academic Press, Inc.
After binding of type I IFN2 (IFN a/b) to the cell surface proteins have yet been reported. Indeed, the complexity
of the antiviral action of MxA would suggest that themore than 50 proteins are induced, whose combined
activities have been associated with both regulation of protein may interact with other cellular proteins to pro-
duce a more general effect. In the case of VSV, phosphor-cellular proliferation and differentiation, and generation
of an antiviral state at the cellular level (1, 2). Of these ylation of its P protein, which may act as regulator of the
viral polymerase, is considered to be an important stepproteins, the antiviral activities of the Mx proteins that are
expressed in virtually all vertebrates have been intensely in transcriptional activation (10). Casein kinase II (CKII)
has been identified as a cellular kinase involved in thisstudied (3). Two human Mx proteins have been identified,
MxA and MxB, that are expressed after type I IFN-treat- process (11–13) and was recently found associated with
purified VSV virions (14). Moreover, CKII-mediated phos-ment in the cytoplasm of most tissue culture cells (4).
Whereas no antiviral activity has yet been found for MxB, phorylation of N-terminal serine/threonine residues of
VSV P protein was shown to be a prerequisite for subse-MxA has been shown to interfere with the replication of
some viruses with negative-stranded RNA genomes such quent phosphorylation at its carboxyterminal domain by
an L-protein-associated kinase (10, 13, 15). Thus it ap-as influenza, vesicular stomatitis virus (VSV), and mea-
sles virus (4 – 7). pears that interference with CKII activity or deregulation
of P protein phosphorylation would be an efficient meansThe antiviral activities of MxA appear complex and are
far from being understood. The protein acts in a virus- for MxA to attenuate VSV transcription. Therefore we in-
vestigated the role that MxA might play in VSV P [Indianaspecific manner, its activity was shown to depend on
both its intracellular location (8) and the host cell back- serotype (IND)] protein phosphorylation using our human
glial cells (U-87) constitutively expressing MxA (7).ground (7), and binding of GTP was found to be a prereq-
uisite for MxA-mediated inhibition of VSV transcription in Similar to other cell lines (5, 16), primary transcription
of VSV (IND) was restricted in U-87-MxA cells after infec-vitro (9). No direct interactions between MxA and viral
tion with a m.o.i. of 10 for 4 hr in the presence of actino-
mycin D and cycloheximide, on average by about 40–1 To whom correspondence and reprint requests should be ad-
50% (not shown). To assess the phosphorylation statusdressed. Fax: /49-931-201-3934.
of P protein, each of two independent U-87-MxA and2 Abbreviations used: CKII, casein kinase II; IFN, interferon; m.o.i.,
multiplicity of infection. U-87-neo cell lines was infected at a m.o.i. of 10 and
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MxA and 4 U-87-neo clones were tested). The extent of
phosphorylation corresponded to the expression levels
of MxA in the individual U-87 clones, which was also
comparable to the levels of endogenous MxA accumu-
lated in other human glial cell lines after IFN-treatment
(Fig. 1b, bottom, and not shown). By a statistically rele-
vant number of experiments (n  20), an average three-
fold stimulation of P protein phosphorylation could be
determined in extracts of U-87-MxA cells.
The kinase activity stimulated in the presence of MxA
also led to an increase of phosphorylation of cellular
proteins when P was omitted from the reaction (Fig. 1c,
FIG. 1. Phosphorylation of VSV P protein in U-87-neo and U-87-MxA lanes 1 and 2), indicating that, as might be expected, P
cells or cell extracts. (a) Each 1 1 106 cells of two independent human protein was not the only target for the kinase. In addition,
glioblastoma U-87-neo (lanes 3 and 4) and U-87-MxA cell clones (lanes
recombinant VSV [New Jersey serotype (NJ)] PO (Fig.1 and 2) (7) was infected with VSV (IND) (m.o.i. of 10) and immediately
1c, lanes 3 and 4) was also hyperphosphorylated afterlabeled in the presence of 250 mCi/ml 32Pi in phosphate-free MEM for
4 hr in the presence of 4 mg/ml actinomycin D. Cell extracts were incubation with U-87-MxA cell extracts. It should be
harvested and adjusted to comparable amounts of P protein concentra- noted that P0 (NJ) generally incorporated phosphates
tions (after Western blotting) prior to immunoprecipitation using a poly- less efficiently when compared to P0 (IND). Conse-
clonal VSV (IND) P antiserum [100 mg of cell extract for both U-87-neo
quently, a significant phosphorylation of cellular proteinslines (lanes 3 and 4) and 450 mg (lane 2) and 500 mg (lane 1) of U-87-
was still detected when P0 (NJ) was used as phosphateMxA cells were used]. Aliquots of either precipitation were reanalyzed
by Western blotting to quantitate the concentration of P. The remaining acceptor in contrast to P0 (IND) (Figs. 1b and 1c). Alto-
aliquots were separated by SDS–PAGE, and P-specific signals were gether, these findings indicated that a cellular kinase
quantified by phosphorimaging. Values obtained were approximately was stimulated in U-87-MxA cells that phosphorylated
identical for the U-87-neo cells (lanes 3 and 4) and 2.8 (lane 2)- and
both cellular proteins and VSV P proteins. Another inter-3.6 (lane 1)-fold higher in U-87-MxA cells. (b) 2.5 mg of the cytoplasmic
pretation, inhibition of a cellular phosphatase active inS100 extracts prepared from the U-87-MxA (lanes 1 to 3) and U-87-neo
cells (lane 4) was used together with 0.25 mg recombinant P0 (IND) regulating the phosphorylation of both P and cellular pro-
for an in vitro kinase reaction in the presence of 10 mCi [g-32P]ATP in teins, was not supported by pulse–chase experiments
kinase buffer (50 mM Tris–HCl, pH 8.0, 100 mM NaCl, 5 mM MgCl2 , using P proteins phosphorylated in vitro (not shown).
2 mM DTT) in a 25-ml reaction for 1 hr at 377. Reaction products were
In order to test whether the MxA-stimulated kinaseseparated by SDS–PAGE and VSV-P-specific signals were quantified
activity could be reconstituted in U-87-neo cells, recombi-by phosphorimaging. Stimulation of P phosphorylation (compared to
U-87-neo extract in lane 4) was threefold (lane 1), fourfold (lane 2), and nant His-MxA was added in increasing concentrations
threefold (lane 3) for the U-87-MxA extracts in this particular experi- to the kinase reaction containing U-87-neo extracts and
ment. The expression levels of MxA in the cell clones used for extract P0 (IND) as phosphate acceptor (ranging from a 1:0.5 to
preparation were determined by Western blot analysis (bottom). (c) 2.5
a 1:10 P:MxA ratio; Fig. 2, lanes 2 to 6). Recombinantmg cytoplasmic extract prepared from U-87-neo (lanes 1 and 3) and a
His-MxA triggered hyperphosphorylation of P0 up toU-87-MxA (lanes 2 and 4) cell line was used for an in vitro kinase
reaction in the absence of added P protein (lanes 1 and 2) or with 0.25 threefold in vitro in a dose-dependent manner (and also
mg P (NJ) (lanes 3 and 4). Stimulation was 4.9-fold for VSV (NJ) P/U-87-
MxA (lane 4)
immediately labeled with 32Pi for 4 hr. Comparable
amounts of P protein (as defined by Western blot analysis
prior to and after precipitation) were precipitated from U-
87-MxA and U-87-neo cells and phosphorylation of P
protein was quantified by phosphorimaging. In U-87-MxA
cells (Fig. 1a, lanes 1 and 2) phosphorylation of P was
on average threefold stronger than in U-87-neo cells (Fig.
FIG. 2. Reconstitution of hyperphosphorylation in U-87-neo cells by1a, lanes 3 and 4). To further address this phenomenon,
recombinant His-MxA. 0.25 mg P0 (IND) was incubated with 2.5 mg U-
cytoplasmic extracts prepared from independent clones 87-neo extract (lane 1) supplemented with recombinant His-MxA pro-
of U-87-MxA or U-87-neo cells were tested for their ability tein at P:His-MxA ratios of 2:1 (lane 2), 1:1 (lane 3), 1:2 (lane 4), 1:5
(lane 5), and 1:10 (lane 6) in the presence of [g-32P]ATP. Lane 7, cellto phosphorylate exogenously added, recombinant, un-
extract without P0, but with added His-MxA (same amount as in lanephosphorylated P protein (P0; purified as His-P0). As
4). Lane 8, P0, phosphorylated by U-87-MxA extract. Lane 9, P0, incu-found in VSV-infected U-87-MxA cells (Fig. 1a), phosphor-
bated with His-MxA. Stimulation of P protein phosphorylation was 1.6-
ylation of P protein by extracts prepared from U-87-MxA fold (lane 2), 2.0-fold (lane 3), 2.9-fold (lane 4), 2.6-fold (lane 5), 2.0-fold
cells was significantly higher than by U-87-neo extracts (lane 6), and 4.2-fold (lane 8) compared to the value obtained with U-
87-neo extract alone (lane 1).(Fig. 1b, lanes 1 to 4; in total, six independent U-87-
AID VY 7911 / 6a16$$$201 05-07-96 01:37:38 vira AP: Virology
243SHORT COMMUNICATION
TABLE 1
Characteristics of Various Kinase Activities (CKII and Those Present in U-87-neo and U-87-MxA Extracts) in Phosphorylating VSV P Proteins
CKII U-87-neo U-87-MxA
Phosphate donors
ATP /// // ///
GTP // / /
Inhibition by heparina Complete Complete Partial
Sensitivity to phosphatase treatmentb No No Partial
Phosphorylation of the VSV P5-mutant No No Weak
Stimulation by His-MxA No (WT P0) Yes (WT P0) No (WT P0)
No (P5) Yes (P5) Yes (P5)
Ability of P protein to stimulate transcription in vitro 100% 100% 100%
Note. Summary of the findings on in vitro phosphorylation and activity of P0 (IND) and a mutant VSV P protein (P5) in which all five aminoterminal
serine/threonine residues have been mutated to alanines (14).
a Concentrations tested ranged from 4 to 15 mg/ml heparin.
b Phosphatase sensitivity was tested using 2 mg Escherichia coli alkaline phosphatase in the presence of 1 mM ATP for 20 min at 307 after in
vitro phosphorylation of P0 by CKII or U-87 extracts (11).
to some extent that of host cell proteins) when added up cells as determined by Western blotting, and CKII activity
was not found to be enhanced when using casein as ato a ratio of 1:2 to U-87-neo extract (Fig. 2, lane 4). In
general, however, phosphorylation levels of both VSV P phosphate acceptor (not shown). Moreover, in contrast
to U-87-neo extracts, CKII-mediated phosphorylation ofand host cell proteins achieved in the reconstitutable
system were lower in most experiments when compared P0 could not be stimulated in vitro after addition of His-
MxA (Fig. 3B, lanes 1 to 6). In addition, while phosphatesto those obtained with U-87-MxA extracts (Fig. 2, lane 8).
This indicated that the recombinant His-MxA protein may acquired after CKII phosphorylation of P0 or incubation
with U-87-neo extracts largely resisted phosphatasebe less active and that contaminating bacterial constit-
uents were not involved in triggering hyperphosphoryla- treatment, U-87-MxA extract-mediated phosphorylation
of P was partially sensitive (not shown). These datation. When added at concentrations of 1:5 and higher,
His-MxA was slightly inhibitory (Fig. 2, lanes 5 and 6). strongly suggested that (1) the kinase stimulated by MxA
was not identical to CKII and (2) a mixture of P1 (phos-No phosphorylation of P0 by His-MxA was observed in
the absence of cell extract (as shown in Fig. 2, lane 9), phorylated by the endogenous CKII) and hyperphosphor-
ylated P was present in U-87-MxA cells.thus MxA does not act as a kinase itself. No stimulation
of VSV P phosphorylation beyond the level obtained with Next we tested whether a mutant P protein, P5 (14),
in which all five aminoterminal serine/threonine residuesU-87-neo extracts was observed in the absence of His-
MxA when using mock-transformed bacterial extract (not were mutated to alanine, would serve as a target for the
MxA-triggered kinase activity. As expected, the mutantshown). His-MxA could not further stimulate P protein
phosphorylation in U-87-MxA extracts (not shown). P protein could not be phosphorylated in vitro by recom-
binant CKII (12, 14) Fig. 4, lane 5) or U-87-neo extractsAs CKII is present in both U-87-neo and U-87-MxA
cells, this kinase would be expected to account for at (Fig. 4, lanes 2 and 3), whereas U-87-MxA extracts were
able to phosphorylate P5 to some extent (Fig. 4, lanes 1least part of the P0 phosphorylation in these cells. The
following experiments were performed to define whether and 4). When recombinant His-MxA was added to the
kinase reactions, all four extracts, but not CKII (Fig. 4,CKII might be the kinase stimulated by MxA (summarized
in Table 1). Like CKII, the kinase stimulated by MxA could lane 10) proved capable of phosphorylating the mutant
P protein (Fig. 4, lanes 6 to 9). As CKII-mediated phos-also use both ATP and GTP as phosphate donors in vitro
(not shown). Heparin, a known inhibitor of CKII (17), at 4 phorylation occurs mainly at two sites within the VSV P
protein (11), a threefold stimulation of phosphorylationmg/ml completely prevented phosphorylation of P0 by 50
mU CKII (Fig. 3A, lanes 1 and 2) and by U-87-neo cell as observed in the U-87-MxA cells should require the
utilization of six additional phosphorylation sites. Theseextracts (Fig. 3A, lanes 5 and 6), indicating that CKII might
have been responsible for phosphorylation of P0 in these are not identical to the CKII sites, as mutant P proteins
lacking these sites still could serve as targets. The usagecells. The same and higher concentrations of heparin
only partially inhibited P protein phosphorylation in U-87- of additional phosphorylation sites was further supported
by preliminary data obtained after proteolytic digestionMxA cell extracts (Fig. 3A, lanes 3 and 4), suggesting
that either extremely high levels of CKII or an additional of hyperphosphorylated P protein (not shown).
Finally, to test whether hyperphosphorylation of Pkinase activity insensitive to heparin were present. Lev-
els of CKII, however, were not increased in U-87-MxA (IND) protein could inhibit VSV transcription in vitro, L
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FIG. 3. The MxA-stimulated kinase activity is different from CKII. (A) P0 was phosphorylated in vitro in the absence or presence of 4 mg/ml heparin
by CKII (lanes 1 and 2, 50mU CKII/25 ml reaction), U-87-MxA extract (lanes 3 and 4), and U-87-neo extract (lanes 5 and 6). As signals seen with the
autoradiograph were very weak, the phosphorimager outprint was used for documentation. (B) P0 was phosphorylated in vitro by 50 mU CKII alone
(lane 1) or by CKII in the presence of recombinant His-MxA, P:His-MxA ratios being 2:1 (lane 2), 1:1 (lane 3), 1:2 (lane 4), 1:5 (lane 5), and 1:10
(lane 6). Lane 7, His-MxA incubated with CKII in the absence of P0.
protein and N-RNA template (both purified from virions) of CKII in these cells. Thus, we assume that sufficient
amounts of P1 were present to stimulate transcription inwere incubated together with P1 (P0 phosphorylated in
the reconstituted system. Since the P protein phosphory-vitro by CKII) or P protein phosphorylated in U-87-neo or
lated in U-87-MxA extracts is likely to represent a mixtureU-87-MxA extracts. However, no inhibition of viral tran-
of P1 and the hyperphosphorylated form, more experi-scription in vitro with any P sample tested was observed
ments will be necessary to separate both forms and test(data not shown). Thus, presently our experiments do
them under these conditions. It is, however, tempting tonot allow us to establish a formal link between MxA-
speculate on hyperphosphorylated P proteins negativelydependent hyperphosphorylation of VSV P protein and
regulating VSV transcription in vivo and in vitro. A recentthe ability of this protein to interfere with primary tran-
study showed a link between hyperphosphorylation ofscription. P proteins phosphorylated by cytoplasmic ex-
VSV M and VSV P proteins and an inhibition of full-lengthtracts of U-87-MxA cells are likely to represent a mixture
RNA synthesis and subsequent secondary transcriptionof hyperphosphorylated P and P1 due to the presence
after treatment of VSV-infected Chinese hamster ovary
cells with okadaic acid, a serine/threonine phosphatase
inhibitor (18). Hyperphosphorylation in this case was
likely to result from an arrest of P protein in the P2 (re-
ferred to as NS2) configuration which is probably
achieved after phosphorylation by L-protein associated
kinase (LAK). As the LAK that has recently been shown
to be active even in the absence of L (19) is apparently
of cellular origin, and the P2 form regulates the transcrip-
tion/replication mode of the RNA polymerase, one could
speculate that MxA may stimulate the LAK and regulate
P1 to P2 conversion. As a more general consideration,
however, it should be reemphasized that VSV P proteins
are not the only targets for the MxA-stimulated kinase,
as indicated by the high overall phosphorylation levelsFIG. 4. In vitro phosphorylation of a mutant P protein (P5) lacking
the N-terminal CKII sites. Recombinant P5 mutant (0.25 mg) was phos- of cellular proteins in U-87-MxA cells in the absence of
phorylated in vitro using extracts prepared from two independent U- P protein (Fig. 1c, lanes 1 and 2). One could also assume
87-MxA (lanes 1 and 6, and 4 and 9, respectively), or U-87-neo cell that deregulation of phosphorylation of one or more cellu-
lines (lanes 2 and 7, and 3 and 8, respectively), or with CKII (lanes 5
lar proteins which may play a role in viral transcriptionand 10). The kinase reactions were carried out in the absence (lanes
would account for inhibition of viral primary RNA synthe-1 to 5) or presence (lanes 6 to 10) of His-MxA (added at a ratio P5:His-
MxA of 1:5). sis. In this case, viral P proteins could just be considered
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